The trading most certainly seems out of reason given the hurdles the company has to overcome plus the flood of cheaper stock that is set to hit the market.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025